- Specialization
- Speech
- Business
- Software Applications
- Market
- Healthcare
- Ecosystem
- Applications
- Customers
- Enterprises
More details
- Organization type
- Commercial Company
- Ecosystem
- Applications
- Business
- Software Applications
- Specialization
- Speech
- Market
- Healthcare
- Customers
- Enterprises
- Delivery models
- Hosted Software
- Revenue models
- Not classified
- Listing status
- Not classified
- Latest equity round
- Pre Seed
- Reported funding amount
- Not classified
About
Obento Health builds a mobile-first, AI-enabled CRM copilot for medical device and medtech field-sales teams. Its voice-to-CRM logging, domain-specific contact data, follow-up creation, and debrief features reduce documentation work and enable more personalized customer interactions.
Market
Obento competes in healthcare CRM and field-sales enablement, focused particularly on physician liaisons and medical-device commercial teams. Its differentiation is a mobile-first AI companion that works alongside an existing CRM, converts voice notes into structured healthcare CRM data, creates follow-ups and contacts automatically, and uses domain-specific healthcare workflows rather than requiring teams to replace their enterprise CRM.
Obento targets B2B healthcare and medical-device organizations with field-based physician-liaison or medical-sales teams; the end users are mobile field reps, while likely buyers are commercial, sales-operations, or CRM leaders. Public evidence does not specify a minimum company size, but the product is designed for organizations whose teams already use a CRM and need faster, more specialized field adoption.
At a Glance
Problem
Obento Health addresses the friction between medical-device field selling and the CRM systems reps are expected to use. Its stated problem is the “love-hate relationship” with CRM: representatives lose time to activity tracking and documentation, leaving less time for customer engagement. The economic pain is therefore primarily a field-productivity problem—manual logging consumes selling time and can make interactions less informed or personalized.
The clearest use case is a medical-device representative finishing a customer visit and recording it immediately by voice rather than typing a report later. By reducing the burden of visit documentation while preserving useful account information, Obento aims to help reps spend more time selling and have better-prepared follow-up conversations.
Product / Service
Obento is a mobile-first CRM co-pilot built specifically for medtech and medical-device sales. Reps can use voice-to-CRM to log visits, access a contact “rolodex” enriched with domain-specific data, and use a debrief mode to surface additional insights after an interaction. The product is designed to fit into existing CRM environments rather than require a wholesale replacement.
The benefit is a lighter-weight workflow for field teams: less administrative work, faster and cleaner activity capture, and more personalized customer interactions. Obento says its integrations can enhance rep productivity from day one, while its healthcare-specific design is intended to reflect the workflows and data needs of medical sales.
Market
Obento competes in B2B healthcare CRM and AI-enabled sales-enablement software, with a narrower initial focus on medical-device and medtech field sales. The competitive set includes broad enterprise CRM platforms such as Salesforce, life-sciences-specific systems such as Veeva Vault CRM, and more focused medical-sales tools such as RepMove. Obento’s differentiation is its mobile, voice-first workflow and domain-specific focus rather than a general-purpose CRM feature set.
The company was founded in 2023, entered Y Combinator’s Summer 2023 batch, and is listed as active with a two-person team. Public evidence shows a YC pre-seed financing round, but the amount is undisclosed. The company’s own website still says “Coming Soon,” and the reviewed sources disclose no named customers, revenue, ARR, or deployment metrics, so the best-supported characterization is early-stage and not yet demonstrating material public commercial traction; literal pre-revenue status is not confirmed.
Founders & Leadership
Funding History
Y Combinator
Recent News
Y Combinator’s medical-devices directory lists Obento Health as an active S2023 company and describes it as redefining CRM for medical field sales. The profile says its healthcare-focused product saves representatives time on documentation and enables more personalized customer interactions.
Dogpatch Design published a case study on Obento Health’s AI CRM copilot for medtech sales, reporting that it helped ship the company’s iOS application v1.0 in under a month and test it with two design partners. The case study also says Obento later paused the product and began exploring a pivot toward Direct Primary Care.
Active Roles
0No active roles right now.
Get notified when they postBusiness Model
Obento appears to operate as a B2B SaaS business, selling access to an AI and mobile CRM platform to medical-device and medtech sales organizations. Public sources do not disclose a specific price or whether billing is per seat, team, or contract.